Illness	Number of cases
Malignant neoplasm of prostate (C61)	337
Hyperplasia of prostate (N40)	336
Carcinoma in situ of other and unspecified sites - Carcinoma in situ of bladder (D09.0)	309
Calculus of kidney and ureter - Calculus of ureter (N20.1)	271
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	157
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	152
Other disorders of bladder (N32.8)	134
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	128
Calculus of kidney and ureter - Calculus of kidney (N20.0)	126
Malignant neoplasm of kidney except renal pelvis (C64)	94

Top 10 treatments

Treatment	Number
Dilatation of the ureters during an operation or endoscopy (5-560.2)	721
Examination of the urethra and the urinary bladder by endoscopy (1-661)	665
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	519
Insertion, exchange or removal of a ureteral stent (8-137.00)	453
Operation using a surgical robot (5-987.0)	424
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1)	261
Injection or administration of medicines into the urinary bladder (8-132.3)	259
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1)	257
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	214
Insertion, exchange or removal of a ureteral stent (8-137.10)	210

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
145	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
96	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
96	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Participation in multi-centre phase III/IV studies
Student training (clinical traineeship / internship year)
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals
HB01	Nurse and health care worker (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)